Literature DB >> 14724679

Aseptic loosening.

P H Wooley1, E M Schwarz.   

Abstract

Although total joint replacement surgery is one of the most successful clinical procedures performed today, bone loss around knee and hip implants (osteolysis), resulting in aseptic loosening of the prosthesis, remains a major problem for many patients. Over the last decade much has been learned about this process, which is caused by wear debris particles that simulate a local inflammatory response and osteoclastic bone resorption. Aseptic loosening cannot be prevented or treated by existing nonsurgical methods. Gene transfer, however, offers novel possibilities. Here, we review the current state of the field and the experimental gene therapy approaches that have been investigated toward a solution to aseptic loosening of prosthetic implants.

Entities:  

Mesh:

Year:  2004        PMID: 14724679     DOI: 10.1038/sj.gt.3302202

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  53 in total

1.  Correlating subjective and objective descriptors of ultra high molecular weight wear particles from total joint prostheses.

Authors:  Brian T McMullin; Ming-Ying Leung; Arun S Shanbhag; Donald McNulty; Jay D Mabrey; C Mauli Agrawal
Journal:  Biomaterials       Date:  2005-08-22       Impact factor: 12.479

2.  The effect of osteoprotegerin gene modification on wear debris-induced osteolysis in a murine model of knee prosthesis failure.

Authors:  Tao Zhang; Haiying Yu; Weiming Gong; Laibo Zhang; Tanghong Jia; Paul H Wooley; Shang-You Yang
Journal:  Biomaterials       Date:  2009-08-07       Impact factor: 12.479

3.  Infectious versus non-infectious loosening of implants: activation of T lymphocytes differentiates between the two entities.

Authors:  Ulrike Dapunt; Thomas Giese; Birgit Prior; Matthias M Gaida; G Maria Hänsch
Journal:  Int Orthop       Date:  2014-03-21       Impact factor: 3.075

4.  SPHK-2 Promotes the Particle-Induced Inflammation of RAW264.7 by Maintaining Consistent Expression of TNF-α and IL-6.

Authors:  Guangpu Yang; Minghui Gu; Weishen Chen; Wenhua Liu; Yinbo Xiao; Haixing Wang; Weiming Lai; Guoyan Xian; Ziji Zhang; Ziqing Li; Puyi Sheng
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

5.  Local effect of IL-4 delivery on polyethylene particle induced osteolysis in the murine calvarium.

Authors:  Allison J Rao; Christophe Nich; Lakshmi S Dhulipala; Emmanuel Gibon; Roberto Valladares; Stefan Zwingenberger; R Lane Smith; Stuart B Goodman
Journal:  J Biomed Mater Res A       Date:  2012-12-05       Impact factor: 4.396

6.  rna interference targeting p110β reduces tumor necrosis factor-alpha production in cellular response to wear particles in vitro and osteolysis in vivo.

Authors:  Jian-bin Huang; Yue Ding; Dong-sheng Huang; Wei-ke Zeng; Zhi-ping Guan; Mao-lin Zhang
Journal:  Inflammation       Date:  2013-10       Impact factor: 4.092

Review 7.  Biomimetic strategies based on viruses and bacteria for the development of immune evasive biomaterials.

Authors:  Matthew T Novak; James D Bryers; William M Reichert
Journal:  Biomaterials       Date:  2009-01-29       Impact factor: 12.479

8.  In vivo imaging of particle-induced inflammation and osteolysis in the calvariae of NFκB/luciferase transgenic mice.

Authors:  Kunihiko Takahashi; Shin Onodera; Harukazu Tohyama; Hyuck Joon Kwon; Ken-ichi Honma; Kazunori Yasuda
Journal:  J Biomed Biotechnol       Date:  2010-09-21

Review 9.  Femoral osteolysis following total hip replacement.

Authors:  R Dattani
Journal:  Postgrad Med J       Date:  2007-05       Impact factor: 2.401

10.  Multi-body simulation of a canine hind limb: model development, experimental validation and calculation of ground reaction forces.

Authors:  Gabriele Helms; Bernd-Arno Behrens; Martin Stolorz; Patrick Wefstaedt; Ingo Nolte
Journal:  Biomed Eng Online       Date:  2009-11-23       Impact factor: 2.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.